Predictive Value of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma in Tumor Recurrence and ...

Background: A significant decrease in catheter-related infections was demonstrated in our earlier randomized controlled trial of central venous catheter (CVC) care in hematologic patients. Objective: ...

Please provide your email address to receive an email when new articles are posted on . Good vascular access continues to be a cornerstone of optimal hemodialysis (HD) for patients with end-stage ...

Intravascular catheter-related bloodstream infections are a major cause of morbidity and mortality in the United States. In the intensive care unit (ICU), the rate of central venous catheter ...

Central venous catheters (CVCs) have improved the management of patients with cancer substantially, by facilitating chemotherapy and supportive therapy. The use of CVCs is associated with ...

The cumulative incidence of CVC-related infection was 24% (25 of 105 patients). Clinically manifest thrombosis occurred in 13 (12%) of 105 patients. In patients with CVC-related infection, the risk of ...

A large number of studies have been published addressing the association of inherited prothrombotic abnormalities with deep vein thrombosis of the leg and pulmonary embolism. 11 In contrast, studies ...

We evaluated the relationship of benefits and risks of PACs in 1000 patients with established acute lung injury in a randomized trial comparing hemodynamic management guided by a PAC with hemodynamic ...

DefenCath is intended for instillation into central venous catheters only. DefenCath ® (taurolidine and heparin) catheter lock solution is now available for inpatient use to reduce the incidence of ...

Please provide your email address to receive an email when new articles are posted on . Using data from the US Renal Data System, researchers identified 74,194 Medicare-eligible patients who initiated ...